In addition to promoting tumor growth by secreting MMP-9 and TNF, NTLS-DCs further inhibit CD8+ T-cell activity by the L-arginine pathway and trigger Treg responses by secreting TGF-[109,119,128,129]. The gene discussed is CD8A; the disease is neoplasm.